{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T10:27:45Z","timestamp":1760783265934},"reference-count":8,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Endocrinol"],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1038\/nrendo.2010.26","type":"journal-article","created":{"date-parts":[[2010,4,23]],"date-time":"2010-04-23T09:48:43Z","timestamp":1272016123000},"page":"248-250","source":"Crossref","is-referenced-by-count":4,"title":["Spironolactone and resistant hypertension"],"prefix":"10.1038","volume":"6","author":[{"given":"Jonathan S.","family":"Williams","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BFnrendo201026_CR1","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1161\/HYPERTENSIONAHA.108.189141","volume":"51","author":"DA Calhoun","year":"2008","unstructured":"Calhoun, D. A.  et al. Resistant hypertension: diagnosis, evaluation, and treatment\u2014a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Hypertension 51, 1403\u20131419 (2008).","journal-title":"Hypertension"},{"key":"BFnrendo201026_CR2","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/S0895-7061(03)01032-X","volume":"16","author":"MK Nishisaka","year":"2003","unstructured":"Nishisaka, M. K., Zaman, M. A. & Calhoun, D. A. Efficacy of low-dose spironolactone in subjects with resistant hypertension. Am. J. Hypertens. 16, 925\u2013930 (2003).","journal-title":"Am. J. Hypertens."},{"key":"BFnrendo201026_CR3","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1161\/HYPERTENSIONAHA.109.140988","volume":"55","author":"F de Souza","year":"2010","unstructured":"de Souza, F., Muxfeldt, E., Fiszman, R. & Salles, G. Efficacy of spironolactone therapy in patients with true resistant hypertension. Hypertension 55, 147\u2013152 (2010).","journal-title":"Hypertension"},{"key":"BFnrendo201026_CR4","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/0002-9149(87)91030-7","volume":"60","author":"X Jeunemaitre","year":"1987","unstructured":"Jeunemaitre, X.  et al. Efficacy and tolerance of spironolactone in essential hypertension. Am. J. Cardiol. 60, 820\u2013825 (1987).","journal-title":"Am. J. Cardiol."},{"key":"BFnrendo201026_CR5","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1161\/HYPERTENSIONAHA.109.131235","volume":"54","author":"E Pimenta","year":"2009","unstructured":"Pimenta, E.  et al. Effects of dietary sodium reduction on blood pressure in subjects with resistant hypertension: results from a randomized trial. Hypertension 54, 475\u2013481 (2009).","journal-title":"Hypertension"},{"key":"BFnrendo201026_CR6","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.1097\/HJH.0b013e3282f254d9","volume":"25","author":"DA Lane","year":"2007","unstructured":"Lane, D. A. & Beevers, D. G. Amiloride 10\u00a0mg is less effective than spironolactone 25\u00a0mg in patients with hypertension resistant to a multidrug regime including an angiotensin-blocking agent. J. Hypertens. 25, 2515\u20132516 (2007).","journal-title":"J. Hypertens."},{"key":"BFnrendo201026_CR7","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.2337\/diabetes.48.8.1623","volume":"48","author":"C Ferri","year":"1999","unstructured":"Ferri, C.  et al. Relationship between insulin resistance and nonmodulating hypertension: linkage of metabolic abnormalities and cardiovascular risk. Diabetes 48, 1623\u20131630 (1999).","journal-title":"Diabetes"},{"key":"BFnrendo201026_CR8","doi-asserted-by":"publisher","first-page":"4472","DOI":"10.1210\/jc.2007-1088","volume":"92","author":"R Bentley-Lewis","year":"2007","unstructured":"Bentley-Lewis, R.  et al. Body mass index predicts aldosterone production in normotensive adults on a high-salt diet. J. Clin. Endocrinol. Metab. 92, 4472\u20134475 (2007).","journal-title":"J. Clin. Endocrinol. Metab."}],"container-title":["Nature Reviews Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrendo.2010.26","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrendo.2010.26.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrendo.2010.26.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T03:35:17Z","timestamp":1684467317000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrendo.2010.26"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5]]},"references-count":8,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["BFnrendo201026"],"URL":"https:\/\/doi.org\/10.1038\/nrendo.2010.26","relation":{},"ISSN":["1759-5029","1759-5037"],"issn-type":[{"value":"1759-5029","type":"print"},{"value":"1759-5037","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,5]]}}}